Lexeo Therapeutics, Inc. (LXEO) Tops Q3 EPS by 51c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q3 EPS of ($0.33), $0.51 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
• BTCS posts $1.5M gross profit in Q2 2026, net loss widens